The microRNA spectrum in 12 body fluids
- PMID: 20847327
- PMCID: PMC4846276
- DOI: 10.1373/clinchem.2010.147405
The microRNA spectrum in 12 body fluids
Abstract
Background: MicroRNAs (miRNAs) are small, noncoding RNAs that play an important role in regulating various biological processes through their interaction with cellular messenger RNAs. Extracellular miRNAs in serum, plasma, saliva, and urine have recently been shown to be associated with various pathological conditions including cancer.
Methods: With the goal of assessing the distribution of miRNAs and demonstrating the potential use of miRNAs as biomarkers, we examined the presence of miRNAs in 12 human body fluids and urine samples from women in different stages of pregnancy or patients with different urothelial cancers. Using quantitative PCR, we conducted a global survey of the miRNA distribution in these fluids.
Results: miRNAs were present in all fluids tested and showed distinct compositions in different fluid types. Several of the highly abundant miRNAs in these fluids were common among multiple fluid types, and some of the miRNAs were enriched in specific fluids. We also observed distinct miRNA patterns in the urine samples obtained from individuals with different physiopathological conditions.
Conclusions: MicroRNAs are ubiquitous in all the body fluid types tested. Fluid type-specific miRNAs may have functional roles associated with the surrounding tissues. In addition, the changes in miRNA spectra observed in the urine samples from patients with different urothelial conditions demonstrates the potential for using concentrations of specific miRNAs in body fluids as biomarkers for detecting and monitoring various physiopathological conditions.
Conflict of interest statement
Figures



Comment in
-
Do platform-specific factors explain microRNA profiling disparities?Clin Chem. 2012 Feb;58(2):472-4; author reply 474-5. doi: 10.1373/clinchem.2011.175281. Epub 2011 Nov 2. Clin Chem. 2012. PMID: 22048406 No abstract available.
-
The Ubiquitous Existence of MicroRNA in Body Fluids.Clin Chem. 2017 Mar;63(3):784-785. doi: 10.1373/clinchem.2016.267625. Epub 2017 Jan 12. Clin Chem. 2017. PMID: 28082463 No abstract available.
Similar articles
-
Investigating the Isolation and Amplification of microRNAs for Forensic Body Fluid Identification.Microrna. 2018;7(3):187-194. doi: 10.2174/2211536607666180430153821. Microrna. 2018. PMID: 29714155
-
Identification of forensically relevant body fluids using a panel of differentially expressed microRNAs.Anal Biochem. 2009 Apr 15;387(2):303-14. doi: 10.1016/j.ab.2009.01.037. Epub 2009 Feb 3. Anal Biochem. 2009. PMID: 19454234
-
High-throughput miRNA sequencing and identification of biomarkers for forensically relevant biological fluids.Electrophoresis. 2016 Oct;37(21):2780-2788. doi: 10.1002/elps.201600258. Epub 2016 Oct 7. Electrophoresis. 2016. PMID: 27557737
-
Advances in body fluid identification: MiRNA markers as powerful tool.Int J Legal Med. 2024 Jul;138(4):1223-1232. doi: 10.1007/s00414-024-03202-6. Epub 2024 Mar 12. Int J Legal Med. 2024. PMID: 38467753
-
Circulating MicroRNAs as Promising Biomarkers in Forensic Body Fluids Identification.Clin Lab. 2015;61(9):1129-35. doi: 10.7754/clin.lab.2015.150207. Clin Lab. 2015. PMID: 26554231 Review.
Cited by
-
Urinary microRNA-1913 to microRNA-3659 expression ratio as a non-invasive diagnostic biomarker for prostate cancer.Investig Clin Urol. 2021 May;62(3):340-348. doi: 10.4111/icu.20200488. Epub 2021 Mar 16. Investig Clin Urol. 2021. PMID: 33834642 Free PMC article.
-
Investigation of Circulating miRNA-133, miRNA-26, and miRNA-378 as Candidate Biomarkers for Left Ventricular Hypertrophy.In Vivo. 2021 May-Jun;35(3):1605-1610. doi: 10.21873/invivo.12417. In Vivo. 2021. PMID: 33910842 Free PMC article.
-
Landscape of Innovative Methods for Early Diagnosis of Gastric Cancer: A Systematic Review.Diagnostics (Basel). 2023 Dec 5;13(24):3608. doi: 10.3390/diagnostics13243608. Diagnostics (Basel). 2023. PMID: 38132192 Free PMC article. Review.
-
Liquid biopsy in the assessment of microRNAs in oral squamous cell carcinoma: A systematic review.J Clin Exp Dent. 2022 Oct 1;14(10):e875-e884. doi: 10.4317/jced.59736. eCollection 2022 Oct. J Clin Exp Dent. 2022. PMID: 36320672 Free PMC article. Review.
-
Changes in circulating microRNA levels associated with prostate cancer.Br J Cancer. 2012 Feb 14;106(4):768-74. doi: 10.1038/bjc.2011.595. Epub 2012 Jan 12. Br J Cancer. 2012. PMID: 22240788 Free PMC article.
References
-
- Nelson P, Kiriakidou M, Sharma A, Maniataki E, Mourelatos Z. The microRNA world: small is mighty. Trends Biochem Sci. 2003;28:534–40. - PubMed
-
- Mishima T, Mizuguchi Y, Kawahigashi Y, Takizawa T, Takizawa T. RT-PCR-based analysis of microRNA (miR-1 and −124) expression in mouse CNS. Brain Res. 2007;1131:37–43. - PubMed
-
- Chang J, Nicolas E, Marks D, Sander C, Lerro A, Buendia MA, et al. miR-122, a mammalian liver-specific microRNA, is processed from HCR mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol. 2004;1:106–13. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous